Allow me to explain my choice of photographs. I choose to spot the picturesque sunset over the Ventura Beach horizon, where I will NOT be attending the upcoming Gordon Research Conference on Oxidative Stress and Disease. For those who will be there, do me a favor and drop me a line on Section 3: Oxidative Stress and Diabetes. Here's what I've got so far...

Alpha-lipoic acid is approved in Germany as a drug for the treatment of diabetic polyneuropathies. Alpha lipoic acid shows evidence of being effective in the treatment of diabetic neuropathy and may be useful in treating some other aspects of diabetes. It may help prevent the oxidation of LDL cholesterol and may be protective against oxidative stress. As much as I wish I could jump forward in time, I'll make a forward-looking statement about an upcoming event and come back to update it, after March 11th. Here's my forecast: the Gordon Research Conferences is holding a conference on Oxidative Stress and Disease and it just so happens that section 3 of the Monday night speakers will address topics such as: A radical explanation for diabetic complications, A role for ROS in the etiopathogenesis of insulin resistance, and Mitochondrial dysfunction and type 2 Diabetes. If you need me to drop names to lift your scientific credence in this convention - the speakers come from Harvard Medical Scool, Yale University School of Medicine and Albert Einstein College of Medicine.

These people don't mess around! I close with a big thank you to the creator of Miracle Muffins, for taking an interest in his mother and sharing it with the rest of us battling frustrating complications of diabetes. I'll be actively checking to see how the experts diagnostically address the role of oxidative stress and what they perceive as the best resolution. Until we hear better in days to come, let's keep betting on the benefits of a little ALA in our day.